• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Quantification of the O- and N-demethylated and the glucuronidated metabolites of codeine relative to the debrisoquine metabolic ratio in urine in ultrarapid, rapid, and poor debrisoquine hydroxylators.

作者信息

Yue Q Y, Alm C, Svensson J O, Säwe J

机构信息

Department of Clinical Pharmacology, Huddinge University Hospital, Sweden.

出版信息

Ther Drug Monit. 1997 Oct;19(5):539-42. doi: 10.1097/00007691-199710000-00010.

DOI:10.1097/00007691-199710000-00010
PMID:9357098
Abstract

The O-demethylation of codeine is polymorphic and catalyzed by CYP2D6. The metabolites of codeine formed through O- and N-demethylation as well as glucuronidation were quantified in the ultrarapid metabolizers of debrisoquine and compared with the normal extensive (EM) and poor metabolizers (PM). The urinary codeine and its seven metabolites were detected after 25 mg codeine in 24 healthy Caucasian subjects with low debrisoquine metabolic ratios (MR, < or = 0.11) and a group of 132 subjects tested earlier with codeine and debrisoquine including 114 EMs (MR < 12.6) and 18 PMs (MR > 12.6). Whereas the O-demethylated metabolites accounted for < 0.4% of the total recovery on average in the PMs and 1.7% to 8.7% in the EMs, they accounted for 15.3% in the 24 subjects with ultrarapid metabolism of debrisoquine. This study suggests that the ultrarapid debrisoquine hydroxylators may develop increased O-demethylated metabolite-dependent effects or side-effects of codeine.

摘要

相似文献

1
Quantification of the O- and N-demethylated and the glucuronidated metabolites of codeine relative to the debrisoquine metabolic ratio in urine in ultrarapid, rapid, and poor debrisoquine hydroxylators.
Ther Drug Monit. 1997 Oct;19(5):539-42. doi: 10.1097/00007691-199710000-00010.
2
Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.可待因O-去甲基化与多态性异喹胍羟基化共分离。
Br J Clin Pharmacol. 1989 Dec;28(6):639-45. doi: 10.1111/j.1365-2125.1989.tb03556.x.
3
O-demethylation of codeine to morphine inhibited by low-dose levomepromazine.低剂量左美丙嗪抑制可待因O-去甲基化生成吗啡。
Eur J Clin Pharmacol. 2009 Aug;65(8):795-801. doi: 10.1007/s00228-009-0640-9. Epub 2009 Mar 24.
4
Indices and graphical approaches for the detection of interindividual and interethnic variations in codeine metabolism.用于检测可待因代谢个体间和种族间差异的指标及图形方法。
Br J Clin Pharmacol. 1997 Sep;44(3):239-44. doi: 10.1046/j.1365-2125.1997.t01-1-00571.x.
5
Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1.右美沙芬代谢能力差和代谢能力强的个体中可待因向吗啡的多晶型转化:与免疫鉴定的细胞色素P - 450IID1存在的关系。
Clin Pharmacol Ther. 1990 Jan;47(1):27-35. doi: 10.1038/clpt.1990.4.
6
Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.由于CYP2D6基因重复导致的超快速代谢者中可待因及其代谢产物吗啡的药代动力学
Pharmacogenomics J. 2007 Aug;7(4):257-65. doi: 10.1038/sj.tpj.6500406. Epub 2006 Jul 4.
7
On the assessment of drug metabolism by assays of codeine and its main metabolites.通过可待因及其主要代谢物的测定评估药物代谢
Ther Drug Monit. 2000 Jun;22(3):258-65. doi: 10.1097/00007691-200006000-00005.
8
3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.3,4-脱氢去甲丙咪嗪,一种由4-羟基去甲丙咪嗪形成的新型去甲丙咪嗪代谢物,它会影响CYP2D6代谢率。
Drug Metab Dispos. 2006 Sep;34(9):1563-74. doi: 10.1124/dmd.105.008920. Epub 2006 Jun 16.
9
Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.可待因及其代谢产物在高加索健康志愿者体内的药代动力学:异喹胍强代谢型与弱代谢型的比较。
Br J Clin Pharmacol. 1991 Jun;31(6):635-42. doi: 10.1111/j.1365-2125.1991.tb05585.x.
10
Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genes.在具有三个或更多功能性CYP2D6基因的受试者中,奎尼丁对异喹胍羟基化的抑制作用。
Br J Clin Pharmacol. 2000 Feb;49(2):180-4. doi: 10.1046/j.1365-2125.2000.00120.x.

引用本文的文献

1
What Do We Know about Opioids and the Kidney?我们对阿片类药物和肾脏了解多少?
Int J Mol Sci. 2017 Jan 22;18(1):223. doi: 10.3390/ijms18010223.
2
Pharmacogenomics of codeine, morphine, and morphine-6-glucuronide: model-based analysis of the influence of CYP2D6 activity, UGT2B7 activity, renal impairment, and CYP3A4 inhibition.基于模型的考来烯胺、吗啡和吗啡-6-葡萄糖醛酸苷的药物基因组学研究:CYP2D6 活性、UGT2B7 活性、肾功能不全和 CYP3A4 抑制对其影响的分析。
Mol Diagn Ther. 2012 Feb 1;16(1):43-53. doi: 10.2165/11597930-000000000-00000.
3
O-demethylation of codeine to morphine inhibited by low-dose levomepromazine.
低剂量左美丙嗪抑制可待因O-去甲基化生成吗啡。
Eur J Clin Pharmacol. 2009 Aug;65(8):795-801. doi: 10.1007/s00228-009-0640-9. Epub 2009 Mar 24.
4
Codeine and clinical impairment in samples in which morphine is not detected.在未检测到吗啡的样本中,可待因与临床损伤情况。
Eur J Clin Pharmacol. 2003 Apr;58(12):785-9. doi: 10.1007/s00228-003-0561-y. Epub 2003 Mar 1.